Loading…
Alkermes plc is projected to rise to $68.18 by 2027, a +31% move from its current price of $51.94. ALKS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $50.78 | $51.98 | $53.20 | +0.07% |
| Jul 14 | $50.33 | $52.01 | $53.75 | +0.14% |
| Jul 15 | $49.99 | $52.05 | $54.19 | +0.21% |
| Jul 16 | $49.72 | $52.09 | $54.57 | +0.28% |
| Jul 17 | $49.48 | $52.13 | $54.91 | +0.36% |
| Jul 18 | $49.27 | $52.16 | $55.22 | +0.43% |
| Jul 19 | $49.08 | $52.20 | $55.51 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $49.08 | $52.20 | $55.51 | +0.50% |
| Week 2 | $48.09 | $52.46 | $57.23 | +1.00% |
| Week 3 | $47.39 | $52.72 | $58.65 | +1.50% |
| Week 4 | $46.85 | $52.98 | $59.93 | +2.01% |
| Week 5 | $46.40 | $53.25 | $61.11 | +2.52% |
| Week 6 | $46.02 | $53.51 | $62.22 | +3.03% |
| Week 7 | $45.70 | $53.78 | $63.30 | +3.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alkermes plc is a biopharmaceutical company that engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products.
It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Alkermes plc (ALKS) is a biopharmaceutical company with a market position of approximately $9.18B in market capitalization and a current price of $55.08. The stock is ranked 975. The company’s portfolio includes treatments for opioid dependence, alcohol dependence, schizophrenia, bipolar I, and pediatric cataplexy or excessive daytime sleepiness, supported by a pipeline of clinical and preclinical candidates in neurological disorders.
A major floor 47.6% below — a decisive break under it would weaken the trend.
The nearest floor, 23.1% below — buyers have tended to step in here.
The nearest ceiling, 6.3% above — a clean break opens room to run.
A major ceiling 23.8% above — clearing it would confirm fresh momentum.
Key ALKS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALKS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $54.07 | Sell | $53.34 | Sell |
| MA 10 | $53.67 | Sell | $52.75 | Sell |
| MA 20 | $50.06 | Buy | $50.37 | Buy |
| MA 50 | $43.04 | Buy | $44.76 | Buy |
| MA 100 | $37.19 | Buy | $39.97 | Buy |
| MA 200 | $33.88 | Buy | $35.96 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.04 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 31.94 | Neutral |
| Williams %R (14) | -35.65 | Info |
| MACD (12,26,9) | -0.17 | Sell |
| ROC (12) | 8.05 | Buy |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 64.35 | Neutral |
| TRIX (15) | 1.16 | Buy |
| Awesome (5,34) | 7.73 | Buy |
| Ultimate (7,14,28) | 55.51 | Neutral |
| Momentum (10) | -0.89 | Sell |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 53.91 | Sell |
| ADX (14) | 44.39 | Buy |
| ATR (14) | 1.10 | Info |
Technically, ALKS shows a bullish sentiment with an RSI of 90. Its 50-day simple moving average sits at $39.07 and the 200-day simple moving average at $32.58. Near-term support is at $36.80 and resistance is at $52.83. The 30-day price range spans from $47.41 to $63.99, indicating recent volatility within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $27.20 | $51.94 | $73.96 | 0% | Neutral | |
| $55.03 | $68.18 | $88.90 | +31% | Bullish | |
| $62.93 | $79.82 | $107.48 | +54% | Bullish | |
| $80.98 | $104.72 | $144.61 | +102% | Bullish | |
| $99.24 | $130.53 | $184.16 | +151% | Bullish | |
| $117.64 | $157.14 | $225.88 | +203% | Bullish | |
| $129.79 | $175.87 | $257.07 | +239% | Bullish | |
| $137.95 | $189.44 | $281.17 | +265% | Bullish | |
| $155.44 | $216.20 | $325.41 | +316% | Bullish | |
| $169.93 | $239.23 | $364.82 | +361% | Bullish | |
| $281.39 | $418.35 | $674.03 | +705% | Bullish | |
| $612.67 | $998.90 | $1,744.72 | +18.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $27.20 | $51.94 | $61.63 | +0.00% |
| August 2026 | $45.61 | $53.62 | $64.57 | +3.23% |
| September 2026 | $46.86 | $55.42 | $67.38 | +3.36% |
| October 2026 | $46.85 | $55.69 | $68.25 | +0.49% |
| November 2026 | $47.62 | $56.85 | $70.14 | +2.08% |
| December 2026 | $49.70 | $59.57 | $73.96 | +4.80% |
Click any year to see its month-by-month ALKS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ALKS to range from $27.20 to $73.96 through 2026. The $51.94 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ALKS price prediction for 2027 points to an average of $68.18 (low $55.03, high $88.90) — a potential gain of +31% on today's $51.94. Buyers look set to stay in control over this stretch.
In 2028, ALKS is projected to trade between $62.93 and $107.48, averaging $79.82 — a potential gain of +54% from today's $51.94. That is up +17% on the projected 2027 average. Momentum favours further upside here.
Alkermes plc's 2029 outlook centres on $104.72, within a $80.98 to $144.61 range. That is up +31% on the projected 2028 average. That marks a +102% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ALKS could reach as high as $184.16, with a base case around $130.53 and support toward $99.24 — roughly +151% from $51.94. Momentum favours further upside here.
Expect ALKS to range from $117.64 to $225.88 through 2031. The $157.14 average target implies a +203% move from current prices. That is up +20% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ALKS price prediction for 2032 points to an average of $175.87 (low $129.79, high $257.07) — a potential gain of +239% on today's $51.94. Momentum favours further upside here.
In 2033, ALKS is projected to trade between $137.95 and $281.17, averaging $189.44 — a potential gain of +265% from today's $51.94. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Alkermes plc's 2034 outlook centres on $216.20, within a $155.44 to $325.41 range. That is up +14% on the projected 2033 average. That marks a +316% change versus current levels. Momentum favours further upside here.
By 2035, ALKS could reach as high as $364.82, with a base case around $239.23 and support toward $169.93 — roughly +361% from $51.94. Buyers look set to stay in control over this stretch.
Expect ALKS to range from $281.39 to $674.03 through 2040. The $418.35 average target implies a +705% move from current prices. That is up +75% on the projected 2035 average. Momentum favours further upside here.
The ALKS price prediction for 2050 points to an average of $998.90 (low $612.67, high $1,744.72) — a potential gain of +18.2x on today's $51.94. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALKS today (≈ 19.252984 ALKS) could be worth
$19,231.89
+$18,231.89 (+1823%) by 2050 · US Dollar
Based on the average projected ALKS price of $998.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALKSwould be worth at today's price.
$1,000 invested in ALKS on Jul 10, 2025 (≈ 32.829942 ALKS) would be worth
$1,705.19
+$705.19 (+70.5%) today · 1.71× · US Dollar
Based on a ALKS entry price of $30.46 vs. today's $51.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $54.58 | $951.63 | -4.8% |
| 1 month ago | $43.84 | $1,184.76 | +18.5% |
| 3 months ago | $33.36 | $1,556.95 | +55.7% |
| 6 months ago | $29.62 | $1,753.54 | +75.4% |
| 1 year ago | $30.46 | $1,705.19 | +70.5% |
| All time (5.0y) ago | $24.44 | $2,125.2 | +112.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALKS forecast.
Our base-case forecast reaches $100.00 around 2029.
Implied market cap at $100.00: $16.67B
The multi-year forecast shows rising averages and significant upside. In 2026, the avg price is $55.08 with a neutral sentiment and 0% ROI. By 2027 the avg rises to $71.05 (ROI 29) and remains bullish, reaching $83.87 in 2028 (ROI 52.3) and $109.51 in 2029 (ROI 98.8).
The 2030 avg is $133.34 (ROI 142.1) and 2031 $161.37 (ROI 193), with 2032 at $179.87 (ROI 226.6) and 2033 at $190.60 (ROI 246). The path continues higher to $221.37 in 2034 (ROI 301.9) and $241.62 in 2035 (ROI 338.7). The forecast extends to $420.19 in 2040 (ROI 662.9) and $977.67 in 2050 (ROI 1675), with bullish sentiment across these distant years.
These numbers illustrate potential upside but are estimates and not guarantees, subject to market and company-specific risks.
Tap a question to reveal the answer.
The average forecast price in 2030 is $133.34 with a minimum of $101.64, a maximum of $187.51, and a forecasted ROI of 142.1%; sentiment is BULLISH.
Forecasts show bullish sentiment in most years after 2026, with rising average prices from $55.08 in 2026 to higher levels by 2030, 2040, and 2050, and notable ROIs in later years. These are estimates, not guarantees.
Yes. The 2031 maximum forecast is $231.10, which exceeds $200 (2030 max is $187.51).
Sentiment is BULLISH; RSI14 is 90; SMA50 is $39.07; SMA200 is $32.58; 30-day range is $47.41 to $63.99; support is $36.80 and resistance is $52.83.
Alkermes plc Community Discussion
0Share your Alkermes plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.